In ₹ Crore except Per Share Latest Annual | HALEOSLABS FY26 | ALBERTDAVD FY26 | VALIANTLAB FY26 | MEDICO FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 25.32× | — | — | ◆ 22.15× | 22.15× +14% | |
| P/B | 1.91× | 1.24× | — | ◆ 0.00× | 0.62× +208% | |
| EV/EBITDA | 12.22× | 52.73× | — | ◆ 0.89× | 26.81× -54% | |
| Market Cap | ₹438 Cr | ₹485 Cr | — | ₹0.1 Cr | ₹243 Cr +81% | |
| Growth | ||||||
| Revenue CAGR 3Y | 1.89% | -0.78% | — | ◆ 13.69% | 6.46% -71% | |
| Revenue CAGR 5Y | 4.68% | ◆ 6.16% | — | — | 6.16% -24% | |
| Net Income CAGR 3Y | 16.09% | — | — | ◆ 21.89% | 21.89% -26% | |
| Revenue YoY (latest Q) | -11.59% | 43.60% | ◆ 146.22% | 81.43% | 81.43% -114% | |
| Net Income YoY (latest Q) | -58.00% | 303.12% | ◆ 1058.93% | 38.49% | 303.12% -119% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 13.38% | 1.64% | 2.69% | 8.25% | 2.69% +397% | |
| Net Income Margin | 5.33% | -0.45% | -1.38% | ◆ 6.35% | -0.45% +1284% | |
| Return on Common Equity | 7.54% | -0.38% | -1.05% | ◆ 17.38% | -0.38% +2084% | |
| Return on Capital Employed | 9.80% | -1.06% | 0.10% | ◆ 18.39% | 0.10% +9700% | |
| Return on Assets | 3.92% | -0.29% | -0.70% | ◆ 8.55% | -0.29% +1452% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.47× | ◆ 0.07× | 0.14× | 0.25× | 0.14× +236% | |
| Interest Coverage | 4.53× | -1.63× | 0.18× | ◆ 7.71× | 0.18× +2417% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹334 Cr | ₹334 Cr | ₹237 Cr | ₹206 Cr | ₹237 Cr +41% | |
| Net Income | ₹17.8 Cr | −₹1.5 Cr | −₹3.3 Cr | ₹13.1 Cr | −₹1.5 Cr +1291% | |
| Total Assets | ₹454 Cr | ₹519 Cr | ₹464 Cr | ₹153 Cr | ₹464 Cr -2% | |
| EPS | ₹57.26 | ₹-2.62 | ₹-0.51 | ₹1.58 | ₹-0.51 +11327% | |
| Book Value per Share | ₹759.29 | ₹686.04 | ₹57.24 | ₹26,774.83 | ₹686.04 +11% | |